Literature DB >> 10964649

Leishmania infantum: stage-specific activity of pentavalent antimony related with the assay conditions.

J Carrió1, M de Colmenares, C Riera, M Gállego, M Arboix, M Portús.   

Abstract

The determination of the intrinsic sensitivity of Leishmania strains to pentavalent antimonials in clinical trials, before treatment is begun, is essential in order to avoid failures and to allow alternative drugs to be chosen. A comparative study of SbV activity on promastigotes, axenic amastigote-like cells, and intracellular amastigotes of Leishmania infantum, when administered in the form of meglumine antimoniate and free, in hydrochloric solution, was performed. Results indicate that the conditions under which the promastigotes were cultured affect the IC(50) obtained, although results were homogeneous when the products were assayed on axenic-like and intracellular amastigotes. The IC(50) obtained for SbV in the form of meglumine antimoniate or in hydrochloric solution on promastigotes cultured in Schneider's medium depends on the growth rate of the culture and therefore could be regulated by modifying the fetal calf serum concentration in the medium. The pH of the culture medium strongly affected the activity of meglumine antimoniate but not that of the SbV hydrochloric solution on promastigotes cultured in Schneider's medium. This influence of pH was observed to a much lesser extent when promastigotes were cultured on M199 or RPMI media. In homogeneous culture conditions, which included the regulation of the promastigote growth rate through the heat-inactivated fetal calf serum concentration in the medium and the dilution of the meglumine antimoniate with Schneider's medium at pH 6.5, the activity of SbV, free or in the form of meglumine antimoniate, was the same in promastigotes, intracellular amastigotes, and axenic amastigote-like cells. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10964649     DOI: 10.1006/expr.2000.4537

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  17 in total

Review 1.  Clinical and experimental advances in treatment of visceral leishmaniasis.

Authors:  H W Murray
Journal:  Antimicrob Agents Chemother       Date:  2001-08       Impact factor: 5.191

2.  Setting new immunobiological parameters in the hamster model of visceral leishmaniasis for in vivo testing of antileishmanial compounds.

Authors:  M A Dea-Ayuela; S Rama-Iñiguez; J M Alunda; F Bolás-Fernandez
Journal:  Vet Res Commun       Date:  2007-01-19       Impact factor: 2.459

3.  In vitro evaluation of the effectiveness and cytotoxicity of meglumine antimoniate microspheres produced by spray drying against Leishmania infantum.

Authors:  G Pujals; J M Suñé-Negre; P Pérez; E García; M Portus; J R Tico; M Miñarro; J Carrió
Journal:  Parasitol Res       Date:  2008-02-17       Impact factor: 2.289

Review 4.  Antimony transport mechanisms in resistant leishmania parasites.

Authors:  Frédéric Frézard; Rubens Monte-Neto; Priscila G Reis
Journal:  Biophys Rev       Date:  2014-01-25

5.  The effect of verapamil on in vitro susceptibility of promastigote and amastigote stages of Leishmania tropica to meglumine antimoniate.

Authors:  Azar Shokri; Iraj Sharifi; Ali Khamesipour; Nozar Nakhaee; Majid Fasihi Harandi; Jafar Nosratabadi; Maryam Hakimi Parizi; Mohammad Barati
Journal:  Parasitol Res       Date:  2011-08-17       Impact factor: 2.289

6.  Antimony uptake systems in the protozoan parasite Leishmania and accumulation differences in antimony-resistant parasites.

Authors:  Christian Brochu; Jingyu Wang; Gaétan Roy; Nadine Messier; Xiao-Yan Wang; Nancy G Saravia; Marc Ouellette
Journal:  Antimicrob Agents Chemother       Date:  2003-10       Impact factor: 5.191

7.  In vitro sensitivity testing of Leishmania clinical field isolates: preconditioning of promastigotes enhances infectivity for macrophage host cells.

Authors:  Raquel Inocêncio da Luz; Marieke Vermeersch; Jean-Claude Dujardin; Paul Cos; Louis Maes
Journal:  Antimicrob Agents Chemother       Date:  2009-09-14       Impact factor: 5.191

8.  Comparison of a high-throughput high-content intracellular Leishmania donovani assay with an axenic amastigote assay.

Authors:  Manu De Rycker; Irene Hallyburton; John Thomas; Lorna Campbell; Susan Wyllie; Dhananjay Joshi; Scott Cameron; Ian H Gilbert; Paul G Wyatt; Julie A Frearson; Alan H Fairlamb; David W Gray
Journal:  Antimicrob Agents Chemother       Date:  2013-04-09       Impact factor: 5.191

9.  Simple colorimetric trypanothione reductase-based assay for high-throughput screening of drugs against Leishmania intracellular amastigotes.

Authors:  Erika van den Bogaart; Gerard J Schoone; Paul England; Dorien Faber; Kristina M Orrling; Jean-Claude Dujardin; Shyam Sundar; Henk D F H Schallig; Emily R Adams
Journal:  Antimicrob Agents Chemother       Date:  2013-11-04       Impact factor: 5.191

10.  Serine proteases profiles of Leishmania (Viannia) braziliensis clinical isolates with distinct susceptibilities to antimony.

Authors:  Anabel Zabala-Peñafiel; Geovane Dias-Lopes; Léa Cysne-Finkelstein; Fátima Conceição-Silva; Luciana de Freitas Campos Miranda; Aline Fagundes; Armando de Oliveira Schubach; Maria Inês Fernandes Pimentel; Franklin Souza-Silva; Lucas de Almeida Machado; Carlos Roberto Alves
Journal:  Sci Rep       Date:  2021-07-09       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.